Bon Secours Liver Institute of Richmond Participating in RESPONSE, a Global Phase 3 Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC) Novel oral medication could provide a new treatment option for people with PBC who have not achieved the recommended treatment goal or who cannot tolerate first-line therapy that prevents them from...